Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
27.74
+0.64 (2.36%)
At close: Apr 17, 2026, 4:00 PM EDT
27.80
+0.06 (0.22%)
After-hours: Apr 17, 2026, 7:58 PM EDT
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $384.32 million as of April 17, 2026. Its market cap has increased by 215.75% in one year.
Market Cap
384.32M
Enterprise Value
380.52M
1-Year Change
215.75%
Ranking
Category
Stock Price
$27.74
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $384.32M, an increase of 459.52%. That is a compound annual growth rate of 36.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 375.46M | 28.99% |
| Dec 31, 2025 | 291.08M | 97.19% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neumora Therapeutics | 391.39M |
| X4 Pharmaceuticals | 390.05M |
| Niagen Bioscience | 388.40M |
| Avalo Therapeutics | 385.49M |
| Ovid Therapeutics | 383.76M |
| Nautilus Biotechnology | 383.49M |
| Cabaletta Bio | 382.95M |
| YD Bio | 382.54M |